Literature DB >> 16469433

Sprouty and cancer: the first terms report.

Ting Ling Lo1, Chee Wai Fong, Permeen Yusoff, Arthur B McKie, Mei-Sze Chua, Hing Y Leung, Graeme R Guy.   

Abstract

The Ras/Erk signaling pathway has a central role in development of multi-cellular organisms as well as in signal transmission in the mature individual. Recently, a family of genes, designated Sprouty, induced by the Ras/Erk pathway was found to specify proteins that inhibited the upstream pathway. Being in a position that is likely to control well-characterized oncogene products suggested that the expression levels of the Sprouty genes may be relevant in human carcinogenesis. Early data on the deregulation of Sprouty expression in breast, prostate and liver cancers is discussed along with the notion that some of them might have potential as tumour markers or that the derived proteins may act as tumour suppressors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16469433     DOI: 10.1016/j.canlet.2005.12.032

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  30 in total

1.  Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.

Authors:  Meredith A Tennis; Michelle M Van Scoyk; Scott V Freeman; Katherine M Vandervest; Raphael A Nemenoff; Robert A Winn
Journal:  Mol Cancer Res       Date:  2010-05-25       Impact factor: 5.852

2.  Sprouty2 Drives Drug Resistance and Proliferation in Glioblastoma.

Authors:  Alice M Walsh; Gurpreet S Kapoor; Janine M Buonato; Lijoy K Mathew; Yingtao Bi; Ramana V Davuluri; Maria Martinez-Lage; M Celeste Simon; Donald M O'Rourke; Matthew J Lazzara
Journal:  Mol Cancer Res       Date:  2015-05-01       Impact factor: 5.852

3.  HECT domain-containing E3 ubiquitin ligase Nedd4 interacts with and ubiquitinates Sprouty2.

Authors:  Francis Edwin; Kimberly Anderson; Tarun B Patel
Journal:  J Biol Chem       Date:  2009-10-28       Impact factor: 5.157

Review 4.  Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract.

Authors:  F J Lovicu; E H Shin; J W McAvoy
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

5.  Prediction of novel genes associated with negative regulators of toll-like receptors-induced inflammation based on endotoxin tolerance.

Authors:  Yan Yang; Hanxiao Sun; Xuemei Mo; Yi Liu; Hongwei Jia; Xiuying Li; Guang Zhang; Qin Li
Journal:  Inflammation       Date:  2012-12       Impact factor: 4.092

6.  Synergistic role of Sprouty2 inactivation and c-Met up-regulation in mouse and human hepatocarcinogenesis.

Authors:  Susie A Lee; Sara Ladu; Matthias Evert; Frank Dombrowski; Valentina De Murtas; Xin Chen; Diego F Calvisi
Journal:  Hepatology       Date:  2010-08       Impact factor: 17.425

7.  Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas.

Authors:  Matthew J Frank; David W Dawson; Steven J Bensinger; Jason S Hong; Wendy M Knosp; Lizhong Xu; Cynthia E Balatoni; Eric L Allen; Rhine R Shen; Dafna Bar-Sagi; Gail R Martin; Michael A Teitell
Journal:  Blood       Date:  2009-01-15       Impact factor: 22.113

8.  Dynamic switch of negative feedback regulation in Drosophila Akt-TOR signaling.

Authors:  Lutz Kockel; Kimberly S Kerr; Michael Melnick; Katja Brückner; Matthias Hebrok; Norbert Perrimon
Journal:  PLoS Genet       Date:  2010-06-17       Impact factor: 5.917

9.  Sprouty genes function in suppression of prostate tumorigenesis.

Authors:  Jennifer L Schutzman; Gail R Martin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-13       Impact factor: 11.205

10.  Sprouty2 association with B-Raf is regulated by phosphorylation and kinase conformation.

Authors:  Suzanne C Brady; Mathew L Coleman; June Munro; Stephan M Feller; Nicolas A Morrice; Michael F Olson
Journal:  Cancer Res       Date:  2009-08-18       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.